Jefferies Starts Abbott Labs (ABT) at Buy
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $55.44 +1.06%
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Rating Summary:
2 Buy, 8 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 0 | New: 0
Join SI Premium – FREE
Jefferies initiates coverage on Abbott Labs (NYSE: ABT) with a Buy. PT $60.00.
The firm states, "Abbott carries an unwarranted discount versus its peers that undervalues the depth and breadth of the company's broad portfolio of products. Fears of new competition to Humira are overdone, in our view, and have clouded investors' ability to appreciate the company's growth potential. We see numerous R&D catalysts and above-consensus revenue and EPS projections which should unlock significant value over the next 12 months."
For more ratings news on Abbott Labs click here and for the rating history of Abbott Labs click here.
Shares of Abbott Labs closed at $51.99 yesterday.
The firm states, "Abbott carries an unwarranted discount versus its peers that undervalues the depth and breadth of the company's broad portfolio of products. Fears of new competition to Humira are overdone, in our view, and have clouded investors' ability to appreciate the company's growth potential. We see numerous R&D catalysts and above-consensus revenue and EPS projections which should unlock significant value over the next 12 months."
For more ratings news on Abbott Labs click here and for the rating history of Abbott Labs click here.
Shares of Abbott Labs closed at $51.99 yesterday.
Create E-mail Alert Related Categories
New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
